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Holmium Laser Enucleation of the Prostate for Benign Prostatic 
Hyperplasia: Effectiveness, Safety, and Overcoming of the Learning 
Curve
Jin Chul Hwang, Sang Myung Park, Jong Bouk Lee
Department of Urology, National Medical Center, Seoul, Korea
Purpose: To examine the efficacy and safety of holmium laser enucleation of the prostate 
(HoLEP) for the surgical treatment of benign prostatic hyperplasia and to estimate the 
time to overcome the learning curve. 
Materials and Methods: From May 2008 to October 2009, 164 consecutive patients 
treated with HoLEP were enrolled in this study. International Prostate Symptom Score 
(IPSS), peak urinary flow rate (Qmax), and postvoid residual urine (PVR) were docu-
mented preoperatively and at 6 weeks and 3, 6, 12, and 18 months postoperatively. The 
164 study subjects were divided into 3 groups (group 1 the first 50 patients treated, 
group 2 the second 50, and group 3 the third 64), and perioperative data and complica-
tions were analyzed in these groups to determine the learning curve. In addition, the 
inverse and upward techniques were compared in terms of the effects and the stability 
of morcellation. 
Results: The mean patient age was 69 years, and the average operation time was 62 
minutes (range, 20-208 minutes). Mean prostate volume was 54.2 ml and mean resected 
tissue weight was 18.6 g. Postoperatively, IPSS and PVR decreased and Qmax in-
creased significantly. Postoperative complications were transient incontinence (8.5%), 
urinary retention (4.3%), hematuria (3.0%), urinary tract infection (1.2%), and urethral 
stricture (0.6%), and intraoperative complications were minor capsular perforation 
(4%) and bladder injury (8%). 
Conclusions: HoLEP was found to be effective and safe regardless of prostate size. We 
recommend that a systematic educational program be established to reduce the learn-
ing curve. 
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INTRODUCTION
Transurethral resection of the prostate (TURP) has been 
considered as the standard for the surgical treatment for 
bladder outlet obstruction induced by benign prostatic hy-
perplasia (BPH). However, ever since Gilling and Fraun-
dorfer reported the concept of holmium laser enucleation 
of the prostate (HoLEP) in 1998 [1], HoLEP has been in-
creasingly used. HoLEP is considered to be at least equiv-
alent to or better than TURP, has been reported to have the 
same long-term record as open prostatectomy, and also has 
been suggested as an endourological surgery that could re-
place open prostatectomy [2,3]. Recently, HoLEP has been 
adopted by several hospitals in South Korea. However, no 
domestic study has been conducted on HoLEP as yet. Thus, 
we decided to describe our early experiences regarding the 
effectiveness and safety of HoLEP and to estimate the 
learning curve, which has been reported to be the largest 
disadvantage of HoLEP [4-6]. Korean J Urol 2010;51:619-624
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TABLE 1. Baseline characteristics of the 164 patients who 
underwent HoLEP   
 Mean  (range)
Age (years)  69 (54-92)
Prostate volume (ml) 54.2 (28-170)
PSA (ng/ml)         5.1 (0.16-36.32)
AUR (No.) 25
Urologic medical Hx. (No.)  
   α-blocker 56
   5ARI   4
   Combined 25
Urologic surgical Hx. (No.)  
   TURP   8
   PVP   2
Data are presented as means, with ranges in parentheses, with
minimum to maximum in parentheses, or numbers. HoLEP: hol-
mium laser enucleation of the prostate, PSA: prostate-specific an-
tigen, AUR: acute urinary retention, Hx.: history, 5ARI: 5α reduc-
tase inhibitor, Combined means that α-blocker and 5ARI were 
co-administered, TUPR: transurethral resection of the prostate, 
PVP: photoselective vaporization of the prostate
MATERIALS AND METHODS
1. Subjects
From May 2008 through October 2009, 164 consecutive pa-
tients who underwent HoLEP for BPH were included in 
this study. Patients were included when their Interna-
tional Prostate Symptom Score (IPSS) was 8 or higher, 
their peak urinary flow rate (Qmax) was 15 ml/s or less, or 
their postvoid residual urine (PVR) was significant. 
Patients were excluded if they had prostate cancer, had 
neurogenic bladder, or had undergone urethral surgery. 
Prostate biopsies were performed to exclude prostate can-
cer when clinically necessary. All procedures were per-
formed by a single surgeon (JBL). Before HoLEP, all pa-
tients underwent a digital rectal examination, serum pros-
tate-specific antigen (PSA), transrectal ultrasonography, 
uroflowmetry, and residual urine measurement, and IPSS 
and quality of life (QoL) scores were determined.   
2. Surgical skills
The HoLEP procedure is composed of two parts: enuclea-
tion for prostate adenoma and morcellation of the removed 
tissues within the bladder [3,7]. Briefly, the median and the 
lateral prostate lobes were dissected off the surgical capsu-
le of the prostate in a retrograde direction from the apex 
and released into the bladder [1,4]. With the capsule plane 
secured, the capsule is peeled off continuously from its top 
and bottom sides in a nine o’clock (right side) and three 
o’clock (left side) direction by using the "push and cut" 
technique. In this manner, all lateral lobes are removed; 
remaining tissues are then trimmed and hemostasis ap-
plied [4,7]. Morcellation is then performed within the 
bladder. After the bladder is sufficiently filled, the removed 
tissues are grasped with the morcellator by suction [4,7]. 
The tissues are then ground into small pieces by using for-
ward and backward movements of the blades before being 
totally evacuated. 
After HoLEP, a 3-way 22 Fr urethral catheter was in-
serted and continuous irrigation was carried out. Bladder 
filling during HoLEP may cause temporary postoperative 
hypotonicity [8]; thus, the urethral catheter was generally 
removed 1 to 2 days later. All retrieved tissues were exam-
ined histologically.
3. Instruments
The VersaPulse PowerSuite
TM (Lumenis, Israel) Holmium 
Laser was used for the enucleation of prostatic adenoma 
at a laser power of 80-100 W. Morcellation was conducted 
by using a percutaneous nephrolithotomy (PNL) nephro-
scope and a VersaCut
Ⓡ Morcellator (Lumenis, Israel). 
4. Outcomes
IPSS and QoL scores and uroflowmetry and residual urine 
were determined at 6 weeks and 3, 6, 12, and 18 months 
after HoLEP and were compared with data obtained pre-
operatively. A questionnaire on complications was also ad-
ministered at the same time. Serum PSA was assessed at 
6 months and 1 year postoperatively. 
5. Learning curve
With respect to the learning curve, the 164 consecutive pa-
tients were divided into three groups, that is, the first 50 
patients, the second 50 patients, and the third 64 patients 
treated, and perioperative data and complications were 
compared between the groups. 
6. Morcellation technique
Morcellation using an inverse (downward) technique was 
used to improve the safety of the morcellation procedure 
from the 85th patient. Morcellation effectiveness and safe-
ty of the inverse and upward techniques were compared. 
During inverse morcellation, the blade is hung upside 
down such that it is directed toward the base of the bladder. 
By positioning a morcellator on top of prostatic tissues, the 
tissues can be held and evacuated from above by suction. 
7. Statistical analysis 
The mean values of continuous variables were used in the 
analysis. Ranges are shown in parentheses. The unpaired 
Student’s t-test was used to analyze differences between 
group mean values, and the Mann-Whitney U test was used 
to analyze non-normally distributed continuous variables. 
p-values of less than 0.05 were considered significant.  
RESULTS
1. Baseline characteristics
Baseline characteristics are listed in Table 1. Forty-three 
patients (26%) had a prostate volume of ＜40 ml, 82 (50%) 
a prostrate volume of 41-59 ml, and 39 (24%) had a volume 
of ＞60 ml as shown in Table 2. Korean J Urol 2010;51:619-624
HoLEP: Effectiveness, Safety, and Overcoming of the Learning Curve 621
TABLE 3. Changes in clinical parameters after HoLEP  
Preoperative (n=164)
Postoperative  
3 months (n=160) 6 months (n=152) 12 months (n=38)
IPSS 25.0 (7-35) 11.4 (5-19)   9.2 (2-16)   7.1 (1-13)
QoL 5.3 (4-6) 3.4 (1-5) 2.3 (0-4) 2.1 (0-4)
Qmax (ml/s)        11.4 (1.1-17.5)         25.2 (14.4-38.0)         22.1 (10.9-33.8)         23.8 (11.8-40.6)
PVR (ml)        88 (22-260)    39 (0-80)    11 (0-40)    10 (0-37)
Data are presented as means, with ranges in parentheses, with minimum to maximum in parentheses. Statistical significance was
accepted for p-values of ＜0.05. HoLEP: holmium laser enucleation of the prostate, IPSS: International Prostate Symptom Score, QoL:
quality of life, Qmax: peak urinary flow rate, PVR: postvoid residual urine 
TABLE 4. Evolution of operative data during the learning curve 
Patients No.
1-50 51-100 101-164
Age (years)   68.9 (57-83)   69.3 (54-92)   68.3 (55-87)
Used laser energy (kJ)
a         142.0 (38.4-330.0)           82.1 (18.5-264.3)           80.1 (20.9-222.3)
Operation time (min)
a     74.2 (40-208)     58.3 (20-133)     56.9 (20-126)
Operation efficiency (g/min)
a         0.25 (0.07-0.49)         0.34 (0.11-0.81)         0.35 (0.09-0.79)
Prostate volume (ml)     53.8 (28-104)     55.0 (33-170)     54.0 (34-159)
Resected weight (g) 17.9 (2-51)   19.2 (4-144)   18.8 (3-126)
Hb loss 0.69 0.71 0.44
Na decrease 0.88 0.09 0.61
Catheterization time (days)
a 2.7 (2-7) 2.3 (1-6) 2.0 (1-4)
Data are presented as means, with ranges in parentheses, with minimum to maximum in parentheses. Hb: hemoglobin, Na: serum 
sodium, 
a: statistically significant at the p＜0.05 level
TABLE 2. Classification of resected weight proportion according 
to prostate volume  
Prostate volume (ml)
Total
   ≤40        41-59         ≥60
No. of patients (%) 43 (26) 82 (50) 39 (24) 164 (100)
Ratio of the resected 22.6 30.5 48.1 34.3
   weight (%)
Statistical significance was accepted for p-values of ＜0.05
2. Outcomes
The mean operative time was 62 minutes (range, 20-208 
minutes) and the mean amount of retrieved prostate tissue 
was 18.6 g (range, 2-144 g), which represented 34.3% of the 
total volume of the prostates. The larger the volume of the 
prostatic gland, the greater the amount of tissue resected, 
as shown in Table 2. 
Changes in clinical parameters after HoLEP are listed 
in Table 3. At 6 months postoperatively, median PVR had 
declined by 87.5%, whereas the mean Qmax rate had in-
creased by 94%, and mean IPSS and median QoL scores had 
decreased by 63.2%, and 56.6%, respectively. In addition, 
mean serum PSA was 1.5 (range, 0.1-11.8), a decrease of 
70.6%. 
Hemoglobin and electrolytes decreased postoperatively 
but not significantly, and there was no case of blood 
transfusion. The mean catheterization time was 2.5 days 
(range, 1-7 days). 
During HoLEP, visual internal urethrotomy was per-
formed in 2 cases for mild urethral stricture, and litho-
tripsy was performed in 5 cases for accompanying bladder 
stones. 
3. Learning curve 
About 50 cases showed a large change in the learning curve. 
Later, a stable learning curve could be maintained. Table 
4 and 5 detail the operative data and the complications 
encountered.
4. Complications
Postoperative complications included transient incon-
tinence (8.5%), urinary retention (4.3%), urinary tract in-
fection (1.2%), and urethral stricture (0.6%). After dis-
charge, 3% of patients required readmission due to hema-
turia, which was resolved conservatively by an indwelling 
urethral catheter for 2 to 3 days. Furthermore, a distinctive 
decrease in transient incontinence was shown in 50 cases 
as seen in Table 5. 
5. Morcellation technique
As seen in Table 6, bladder injury was effectively overcome 
by securing stable visual sites during morcellation by the Korean J Urol 2010;51:619-624
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TABLE 5. Intraoperative and postoperative complications during
the learning curve 
Patients No.
Total
1-50   51-100   101-164
Change to TURP during HoLEP
a  6
c 00 6
Minor capsular perforation
a 41 16
Bladder injury
b 93 1 1 3
Transfusion 0 0 0 0
Recatheterization due to retention
b 42 17
Re-admission due to hematuria 2 2 1 5
Transient incontinence
b,d 74 3 1 4
Urinary tract infection 1 1 0 2
Urethral sticture
a 10 01
Bladder neck contracture 0 0 0 0
Re-operation due to remnant  0 0 0 0
   adenoma
TURP: transurethral resection of the prostate, HoLEP: holmium
laser enucleation of the prostate, 
a: statistically significant differ-
ences between patients 1-50 and 51-100 (p＜0.05), 
b: statistically
significant differences between patients 1-50, 51-100, and 
101-164 (p＜0.05), 
c: all were within 20 consecutive cases, 
d: usu-
ally resolved ＜3 months after HoLEP
TABLE 6. Comparison of operative data regarding morcellation 
for the upward and inverse (downward) techniques 
Upward Inverse (downward)
technique technique
Patients No.  1-84 85-164
Mean morcellation time (min) 14.3±8.6 6.1±7.4
Morcellation efficiency (g/min)   1.93±1.14 4.06±0.95
Bladder injury 11 2
  Superficial   6 2
  Deep
a   5 0
Catheter time (days)   2.6±1.7 2.0±1.2
Data presented are Means±SD or numbers. Statistical sig-
nificance was accepted for p values of ＜0.05. 
a: injury involved the
muscular layer and required an indwelling urethral catheter for
more than 3 days postoperatively
inverse (downward) technique.   
6. Pathology
Prostate cancer was detected histologically in 3 (2%) pa-
tients postoperatively. 
DISCUSSION
Recently, HoLEP has emerged as an attractive surgical al-
ternative to the treatment of bladder outlet obstruction due 
to BPH [9]. The HoLEP technique is a method of removing 
all prostatic adenoma endourologically and might be as ef-
fective as open prostatectomy and theoretically reduce 
complications [3,10,11]. Kuntz et al reported in a study in-
volving 120 patients with a 5-year follow-up study that 
HoLEP and open prostatectomy showed the same level of 
clinical improvement and that BPH did not recur; thus, it 
was concluded that HoLEP is an endourological alter-
native for open prostatectomy [3]. In addition, other stud-
ies reported that open prostatectomy was better in the in-
dices of operation time and removed tissue weight, but that 
HoLEP was better in the indices of catheterization time, 
hospital stay, and bleeding or transfusion. The reason for 
HoLEP having less removed weight was thought to be due 
to tissue evaporation by laser during HoLEP [3,6,9,12].
Previous studies have compared HoLEP and TURP and 
found that TURP was better in terms of operation time, 
whereas HoLEP was better in terms of resected tissue 
weight, catheterization time, hospital stay, and bleeding 
or transfusion [6,13-15]. Furthermore, there was no differ-
ence in the uroflowmetry or change of symptom scores be-
tween both groups after 2 years of follow-up observations 
[14,15]. Kuntz et al reported in a randomized study of 200 
patients with a 1-year follow-up that HoLEP was better than 
TURP in terms of hospital stays, hemoglobin decrease, 
clinical improvement, and residual urine [2]. Furthermore, 
HoLEP was shown to be effective and safe for treating con-
current BPH in patients administered anticoagulants, in 
patients with a hemorrhagic disorder, and in patients with 
stones in the upper urinary tract or bladder [16-20]. 
However, the major disadvantage of HoLEP concerns 
overcoming the learning curve, which requires experience 
and time. Many surgeons have mentioned that although 
the HoLEP method was more difficult than TURP, one 
could overcome the difficulty with self-learning [5,21-23]. 
Seki et al reported an enucleation efficiency study involv-
ing 70 patients who underwent HoLEP and were divided 
into 7 groups of 10 patients each. In the first group, enuclea-
tion efficiency was 0.3 g/min but in the last group it had in-
creased to 0.75 g/min, showing that the accumulation of ex-
perience improved the learning curve [24]. Placer et al 
studied the learning curve of HoLEP in 125 patients who 
were divided into 5 groups in time-sequence order; they 
compared the first and last groups [4]. Enucleation effi-
ciency was found to markedly increase from 0.3 g/min to 
1 g/min, and mean operation times and the amount of energy 
used showed decreases of 47% and 45%, respectively, be-
tween these groups. Furthermore, regarding transient in-
continence, which is representative of the complications of 
HoLEP, the prevalence in the first group of 50 patients was 
28%, but that in the last group of 50 patients was markedly 
reduced by 6%. Thus, they mentioned that improvement 
of the learning curve had a direct effect of decreasing com-
plications [4].   
Recently, Shah et al reported the results of a study in-
volving 162 patients who were divided into 3 groups by se-
quence of HoLEP (first group: 1-50, second group: 51-100, 
and third group: 101-162). Eight patients (5%) out of 162 
showed a failure of lateral lobe enucleation, and thereby 
were switched to TURP. All 8 were among the first 25 treat-
ed, and enucleation efficiency was improved approaching 
a high point plateau after 50 cases. Experience with about 
50 cases would be necessary to reach the expert level in this Korean J Urol 2010;51:619-624
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surgical technique, HoLEP. Also, instruction by more ex-
perienced urologists would bring about better results and 
shorten the learning curve [21]. In our study, HoLEP learn-
ing was self-taught and accomplished alone after attend-
ing as an observer and watching the self-learning video, be-
cause the opportunity to be supervised by an experienced 
urologist was not available in Korea. In the case of our 
study, enucleation failure for the first 20 cases led to 
switching to TURP in 6 patients (4%). This asserts the ne-
cessity of a systemized mentoring program. 
The most significant complication that can develop in 
HoLEP is bladder injury during morcellation. Generally, 
its frequency is less than 10%, and most degrees of the in-
jury are not severe [22]. However, introduction of morcella-
tion by the inverse (downward) technique was effective at 
reducing bladder injury. The inverse (downward) techni-
que could prevent blocking of the view of the posterior wall 
of the bladder by the tissues during morcellation and help-
ed to maintain a sufficient distance of the morcellator from 
the bladder wall. A bladder wall injury by the blade during 
HoLEP would grasp the bladder trigon area, which is rela-
tively safer, thus preventing the worst scenario or sequelae. 
In the case of our study, the morcellation time was sig-
nificantly reduced and bladder injury and urethral cathe-
terization time were also distinctively reduced (Table 6).
The frequency of urethral stricture and bladder neck con-
tracture by HoLEP was also within the 5% range, which 
was similar to that of TURP [2,25]. In our study, the short 
follow-up observation period did not allow assessment of 
this issue.  
Transient incontinence is a postoperative complication 
of HoLEP that distresses many surgeons. The surgical fea-
tures of total prostatic adenoma removal by HoLEP tend 
to induce higher frequencies of incontinence than does 
TURP and the condition lasts longer [26,27]. The incon-
tinence frequency was reported to be 1% through 44%. 
However, 3-10% is most common [4,5,22,28,29]. Higher in-
continence frequency is reported during the initial try with 
less experience and is thought to be associated with the 
learning curve [4,5]. The duration of postoperative incon-
tinence is usually 3 to 6 months. Some surgeons reported 
permanent incontinence. However, incontinence is mostly 
a transient occurrence [4,22,28,29]. An antiinflammatory 
or anticholinergic drug could be used to regulate incon-
tinence [22,28]. We also realized that the frequency of tran-
sient incontinence was markedly reduced as the number 
of cases increased. The reasons for such a decrease in the 
frequency of incontinence were considered to be improve-
ment of the learning curve, efforts to reduce thermal in-
juries on the apex level by a laser, and the process of saving 
some amount of anterior fibromuscular stroma tissues 
[13,28,30]. 
CONCLUSIONS
HoLEP has fewer complication and is effective. It is a method 
that may completely remove prostatic adenoma tissues. In 
particular, its clinical effectiveness is excellent regardless 
of prostate size, and it is effective even in cases with a pros-
tate volume of 100 ml or more. However, for self- taught sur-
geons, about 50 cases are needed to reach the experienced 
level; thus, we suggest the establishment of a systematic 
educational program to shorten the learning period. 
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